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Objectives: This study was done to compare the anesthetic efficacy of 4% articaine with 1:100,000 epinephrine 
with that of 2% lidocaine with 1:80,000 epinephrine during pulpectomy in patients with irreversible pulpitis for 
inferior alveolar nerve block in mandibular posterior teeth.
Material and Methods: Patients with irreversible pulpitis referred to the Department of Conservative Dentistry 
and Endodontics, K.D. Dental College, randomly received a conventional inferior alveolar nerve block containing 
1.8 mL of either 4% articaine with 1:100,000 epinephrine or 2% lidocaine with 1:80,000 epinephrine. After the 
patient’s subjective assessment of lip anesthesia, the absence/presence of pulpal anesthesia through electric pulp 
stimulation was recorded and the absence/presence of pain was recorded through visual analogue scale.
Results: The pulpal anesthesia success for articaine (76%) was slightly more than with lidocaine (58%) as measu-
red with pulp tester as well as for the pain reported during the procedure the success rate of articaine (88%) was 
slightly more than that of lidocaine (82%) although the difference between the two solutions was not statistically 
significant.
Conclusions: Both the local anesthetic solutions had similar effects on patients with irreversible pulpitis when used 
for inferior alveolar nerve block.
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Articaine comparatively is a new anesthetic, which has 
recently been introduced in Brazil and was approved for 
use in the United States in April 2000 (1). It is the most 
commonly used local anesthetic in Canada and in se-
veral European countries (2,3). In Germany, it accounts 
for 80% of all local anesthetics used for endodontic 
treatments (4,5).
Articaine is the center of heated discussions among den-
tal surgeons as it has a faster onset and higher success ra-
tes than lidocaine as well as it has been demonstrated to 
increase the risk of paresthesia which could not be con-
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firmed in a recent study (6-8). Articaine has been shown 
to be a significantly better anesthetic agent as compared 
to lidocaine for infiltrations (9-11).
 So far, research on the anesthetic efficacy of articaine 
in patients with irreversible pulpitis for inferior alveolar 
nerve block has been very limited (12-14). Therefore, 
to contribute to a more profound knowledge about the 
quality of articaine as a local anesthetic for endodon-
tic treatments, the purpose of the present study was to 
compare the anesthetic efficacy of 4% articaine with 
1:100,000 epinephrine with 2% lidocaine with 1:80,000 
epinephrine for IAN blocks in patients with mandibular 
posterior teeth experiencing pulpitis.
Material and Methods 
One hundred adult patients [n=100] aged between 18-
50 years participated in this prospective, randomized, 
double-blind clinical study. The patients included in this 
study had been admitted to the Department of Conser-
vative Dentistry and Endodontics, K.D. Dental College 
with a clinical diagnosis of irreversible pulpitis. The pa-
tients had at least 1 adjacent tooth plus a healthy con-
tralateral canine or, alternatively, a contralateral canine 
without deep carious lesions, extensive restoration, ad-
vanced periodontal disease, history of trauma, or sensi-
tivity and gave a positive response on electric pulp tes-
ting of the diseased tooth and a prolonged response with 
moderate to severe pain to a cold testing using Roeko 
Endo-Frost [Roeko, Langenau, Germany]. While Pa-
tients who took medication potentially interacting with 
any of the anesthetics or with systemic disorders, history 
of sensitivity to anesthetic agents, presence of periodon-
tal ligament [PDL] widening or periapical radiolucency 
or pregnancy were not included.
The study was approved by the Committee on the Ethics 
of Research on Human Beings and each patient gave 
written informed consent to participate in the study. Be-
fore the IAN block injections, the tooth with irreversible 
pulpitis, the adjacent tooth, and the contralateral canine 
were tested for pulp vitality with an electric pulp stimu-
lator. The electric pulp stimulation of the contralateral 
canine, which had not been anesthetized, was used as 
control to ensure that the equipment was working pro-
perly and that patients were responding adequately.
The 100 participants were divided into 2 groups of 50 pa-
tients, who received IAN injections of 1.8 mL [equivalent 
to 1 cartridge] of either 2% lidocaine with 1:80,000 epine-
phrine or 4% Articaine with 1:100,000 epinephrine.
To ensure the blindness of the study, the label on the 
cartridges was removed and the cartridges were coded. 
1 cartridge [1.8 mL] of either anesthetic solution was 
sealed in envelopes. At the time of application, one re-
searcher, who administered the anesthesia injections, 
chose one of the envelopes at random. Electric pulp sti-
mulations to assess pulpal anesthesia were performed 
by a colleague to guarantee that the anesthetic solution 
remained unknown and thus maintain the double-blind-
ness of the study. Before the IAN block injections, the 
tooth with irreversible pulpitis, the adjacent tooth, and 
the contralateral canine were tested for pulp vitality with 
an electric pulp stimulator.
For the injections, a side-loading carpule syringe fitted 
with a 27-gauge 0.4 X 35 mm needle and equipped with a 
blood aspiration device and a thumb ring was used. Blood 
aspiration tests were carried out before each anesthesia 
injection as well as when changing needle position.
The cartridge of the respective anesthetic solution was 
applied as follows:
The index finger and thumb were used to palpate over the 
anterior border of the ramus of the mandible until the coro-
noid notch is felt. The palpating finger was then moved lin-
gually across the retromolar triangle and onto the internal 
oblique ridge. The syringe was directed from the premolar 
region of the opposite side, and the needle was inserted until 
establishing bone contact. Thereafter, the needle was with-
drawn 1–2 mm, the blood was aspirated, and the remaining 
1.5 ml of anesthetic solution was slowly injected. The nee-
dle was then withdrawn to half its length and brought on the 
same side and remaining 0.3 ml was injected to anesthetise 
the lingual nerve. The average injection time for each car-
tridge was approximately 2 minutes.
Ten minutes after the IAN block, subjective lip anesthe-
sia was evaluated by asking the patient whether his/her 
lip was numb. Thereafter and immediately before the 
pulpectomy, the electric pulp stimulations were repeated 
to determine pulpal anesthesia. During the pulpectomy 
procedure, the patients were instructed to report any pa-
inful discomfort.
To evaluate the intensity of pain during the pulpectomy, 
a visual analogue scale was used: 0, no pain; 1, mild, 
bearable pain; 2, moderate, unbearable pain; 3, severe, 
intense, and unbearable pain. The anesthesia was defined 
as successful when the dentist accessed the pulp cham-
ber without pain being reported by the patient [pain sco-
res 0 or 1]. In these cases, the pulpectomy procedure was 
continued. Pain scores of 2 or 3 classified the IAN block 
as unsuccessful. In these cases, an intrapulpal anesthesia 
was performed, and the pulpectomy was finalized. This 
complementary anesthesia was not evaluated, because it 
was beyond the scope of this study.
The responses to the electric pulp tester [negative or po-
sitive] and the pain [“with pain,” scores 2 or 3, or “wi-
thout pain,” scores 0 or 1] recorded in the 2 test groups 
[articaine solution and lidocaine solution groups] were 
compared by using the χ2 test. Potential differences in 
age between the 2 groups were analyzed with T-test. The 
Mann-Whitney U test was used to compare the distribu-
tions of types of teeth with irreversible pulpitis in both 
groups. For all performed tests, the level for significance 
of differences was taken as P < .05.
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Table 1. Types of Teeth with Irreversible Pulpitis.
Fig. 2. Bar graph of the occurrence of pain (percent) after the respec-
tive IAN block solutions.
Fig. 1. Bar graph of responses to the pulp tester (percent) after the 
respective IAN block solutions.
Results
In the present study, there were no statistically signifi-
cant differences between the patients of the 2 test groups 
[articaine versus lidocaine solution] concerning gender 
distribution [articaine group, 60% female; lidocaine 
group, 46% female; P = 0.161], age [average age: arti-
caine group, 26.46 years; lidocaine group, 28.90 years; 
P=0.233], and the types of teeth with irreversible pulpi-
tis [P = 0.188] (Table 1).
Mann-Whitney U test was also carried out for the types 
of teeth with irreversible pulpitis in the two groups and 
no statistically significant difference was found between 
types of teeth with irreversible pulpitis [p=0.123].
All 100 patients [100%] reported subjective lip anesthe-
sia 10 minutes after the IAN block. Before the pulpec-
tomy procedure, 38 patients [76%] of the articaine group 
and 29 patients [58%] of the lidocaine group exhibited 
pulpal anesthesia (Fig. 1), i.e., a negative response to 
electrical stimuli generated with an electric pulp tester. 
However, this slight difference between the 2 experimen-
tal groups was not statistically significant [P= 0.056].
During the pulpectomy, 6 patients of the articaine group 
[12%] and 9 patients of the lidocaine group [18%] repor-
ted pain [pain scores 2 and 3]. Again, this difference was 
not statistically significant [P = 0.401] (Fig. 2).
Discussion
In our study there are no significant differences between 
the patients of the 2 test groups [articaine versus lido-
caine solution] regarding their gender, age, and type of 
posterior tooth with irreversible pulpitis. Consequently, 
any potential effects of these parameters can be minimi-
zed or even neglected, and the results obtained with both 
anesthetic solutions can be directly compared.
The Anesthetic solution of 2% lidocaine with 1:80,000 
epinephrine was used in the study as these cartridges are 
most commonly used the institution in which the study 
was carried. The concentration of epinephrine does not 
affect the degree of anesthesia obtained with 2% lidocai-
ne for inferior alveolar nerve block (15).
Our study demonstrates that although both local anesthe-
tic solutions always resulted in profound lip anesthesia 
10 minutes after their application, pulpal anesthesia is 
not necessarily achieved. Only 76% of the patients in the 
articaine group and 58% of the patients in the lidocaine 
group exhibited pulpal anesthesia, i.e., a negative res-
ponse to electrical stimuli generated by an electric pulp 
tester which is in confirmation to the results of another 
study that had investigated the effect of articaine and li-
docaine used for inferior alveolar nerve block (1).
In the articaine group, 12% of the patients experienced 
pain during the pulpectomy. The percentage of patients 
reporting pain during the treatment was only insignifi-
cantly higher in the lidocaine group [18%].
The results of the study point to the fact that neither of 
the local anesthetic solutions used guarantees a complete 
absence of pain during pulpectomy. Although the suc-
cess rate is slightly more with the articaine solution than 
with the lidocaine solution, this difference was not sta-
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tistically significant. Although 42% of all assessed pos-
terior teeth had responded negatively to the electric pulp 
test, the patients reported pain during the subsequent en-
dodontic treatment. The similarities between the results 
of this study and those by other authors give rise to the 
assumption that a negative response of symptomatic tee-
th with pulp inflammation to the pulp tester is no reliable 
indicator for analgesia (16,17).
In this study the anesthesia was defined as successful 
when the dentist accessed the pulp chamber without pain 
being reported by the patient [pain scores 0 or 1] mea-
sured by the scale made for measuring visual analogue 
scale. In these cases, the pulpectomy procedure was con-
tinued. Pain scores of 2 or 3 classified the IAN block as 
unsuccessful.
So far, only two other studies, performed by Claffey et 
al. 12 and Tortamano et al. (13), compared the efficacy 
of IAN blocks containing 4% articaine with 1:100,000 
epinephrine with those containing 2% lidocaine with 
1:100,000 epinephrine in patients with irreversible pul-
pitis. In the study by Claffey et al. (12), the success rates 
were 24% [9 of 37 patients] for IAN blocks with arti-
caine solution and 23% [8 of 35 patients] for lidocaine 
solution, while in the study by Tortamano et al. the suc-
cess rates were 65% with articaine solutions and 45% 
with lidocaine solutions. In both the studies the sample 
size was small and this may have been the reason for the 
statistically insignificant difference in the two with arti-
caine showing slightly better result than lidocaine.
So, in our study with large sample size of 100 patients was 
taken, the success rates were 88% with articaine and 82% 
with lidocaine which are higher than the previous studies. 
These differences in success rates could be also due to 
potential population differences between both studies.
Also, the dosage used by Claffey et al. was 2.2 ml while 
that used by Tortamano et al. was 3.6 ml. The dose used in 
our study was 1.8 ml as recommended by C.Richard Ben-
nett (18) and it is the dosage commonly used [1 cartridge] 
for inferior alveolar nerve blocks in the institution.
The increase in dosage of local anesthetic also increases 
its efficacy is not entirely supported by the literature. It 
has been postulated that once the effective volume of lo-
cal anesthetic is attained, no further benefit can be achie-
ved through a further increase in dosage. In the case of 
2% lidocaine with adrenaline, this effective volume has 
been reported to be upto 2.0 ml of solution (19).
The superiority of articaine over lidocaine for inferior 
alveolar nerve blocks in patients with irreversible pulpi-
tis once again could not be statistically corroborated by 
the clinical study even with a large sample size. Both so-
lutions presented a similar behaviour, and both were not 
entirely efficient in controlling pain during the treatment 
of irreversible pulpitis. Since this study showed no diffe-
rence in the efficacy of both the dental anesthetic agents 
in controlling pain during the treatment of irreversible 
pulpitis, articaine which has lesser toxicity could be 
substituted with lidocaine as dental anesthetic agent for 
IAN blocks in patients with irreversible pulpitis.
More number of such studies is required to make Ar-
ticaine as popular anesthetic agent for dental treatment 
procedures.
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